Search

everythinglearnresearchcommunity

for

Search:↓

Sam Shuster identified three types of hair loss in psoriasis and emphasized the need for better research to understand them.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

People with HIV and low T cell counts have more hair and scalp problems.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Finasteride and dutasteride increase sexual dysfunction reports.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.